Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

Alzheimer’s DiseaseDementia

Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies

Lancet Neurol.

Ding J, Davis-Plourde KL, Sedaghat S, Tully PJ, Wang W, Phillips C, Pase MP, Himali JJ, Gwen Windham B, Griswold M, Gottesman R, Mosley TH, White L, Guðnason V, Debette S, Beiser AS, Seshadri S, Arfan Ikram M, Meirelles O, Tzourio C, Launer LJ

doi: 10.1016/S1474-4422(19)30393-X.

Aging and Cognitive Functions

High performance plasma amyloid-β biomarkers for Alzheimer's disease

Nature

Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Doré V, Fowler C, Li QX, Martins R, Rowe C, Tomita T, Matsuzaki K, Ishii K, Ishii K, Arahata Y, Iwamoto S, Ito K, Tanaka K, Masters CL, Yanagisawa K

doi: 10.1038/nature25456.

Impact of home visit capacity on genetic association studies of late-onset Alzheimer's disease

Alzheimers Dement.

Fardo DW, Gibbons LE, Mukherjee S, Glymour MM, McCormick W, McCurry SM, Bowen JD, Larson EB, Crane PK

doi: 10.1016/j.jalz.2017.01.012.

Alzheimer’s DiseaseDementia

Postmenopausal hormone therapy and Alzheimer disease: A prospective cohort study

Neurology.

Imtiaz B, Tuppurainen M, Rikkonen T, Kivipelto M, Soininen H, Kröger H, Tolppanen AM

doi: 10.1212/

Alzheimer’s Disease

Prediction of Autopsy Verified Neuropathological Change of Alzheimer's Disease Using Machine Learning and MRI

Front Aging Neurosci.

Kautzky A, Seiger R, Hahn A, Fischer P, Krampla W, Kasper S, Kovacs GG, Lanzenberger R

doi: 10.3389/fnagi.2018.

Dementia

Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes

JAMA Neurol.

Pase MP, Beiser AS, Himali JJ, Satizabal CL, Aparicio HJ, DeCarli C, Chêne G, Dufouil C, Seshadri S

doi: 10.1001/jamaneurol.

Aging and Cognitive FunctionsDementia

A 'Framingham-like' Algorithm for Predicting 4-Year Risk of Progression to Amnestic Mild Cognitive Impairment or Alzheimer's Disease Using Multidomain Information

J Alzheimers Dis.

Steenland K, Zhao L, John SE, Goldstein FC, Levey A, Alvaro A; Alzheimer’s Disease Neuroimaging Initiative

doi: 10.3233/JAD-170769.

Alzheimer’s DiseaseAnxiety and Depression

Updating the evidence for an association between anxiety and risk of Alzheimer's disease: A meta-analysis of prospective cohort studies

J Affect Disord.

Santabárbara J, Lipnicki DM, Bueno-Notivol J, Olaya-Guzmán B, Villagrasa B, López-Antón R

doi: 10.1016/j.jad.2019.11.065.

Amyotrophic Lateral SclerosisParkinson’s Disease

Peripheral Immune Biomarkers and Neurodegenerative Diseases: A Prospective Cohort Study with 20 Years of Follow-up

Ann Neurol.

Yazdani S, Mariosa D, Hammar N, Andersson J, Ingre C, Walldius G, Fang F

doi: 10.1002/ana.25614.

Related content